Synartro is a Swedish pharmaceutical company developing local injection treatments aiming to provide superior and sustained efficacy without systemic side-effects. This is achieved by combining our patented delivery technology with existing proven drugs. Our pre-clinical lead program focuses on a novel therapy using our compound SYN321 for the treatment of osteoarthritis (OA). Currently this disease leaves up to 50% of patients without adequate pain relief.
| Website | http://www.synartro.com |
| Revenue | $3 million |
| Employees | 6 (2 on RocketReach) |
| Founded | 2011 |
| Phone | +46 73 817 19 42 |
| Industry | Pharmaceutical Manufacturing, Manufacturing General, Therapeutics, Drug Discovery, Manufacturing, Health Care |
| Keywords | Pharmaceutical, Drug Delivery, Injection Therapy, Local Anesthesia, Sustained Release, Biotechnology, Patented Technology, Pain Management, Medical Technology, Pharmaceutical Research, Drug Development, Clinical Trials, Innovative Treatments, Targeted Therapy, New Drugs, Health Technology, Treatment Solutions, Medical Devices |
| Competitors | Veeva Systems, Oracle, Medidata Solutions, Parexel, Synarc, Covance, PPD, Clinipace Worldwide, ICON plc, Charles River Laboratories +37 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies |
Looking for a particular Synartro employee's phone or email?
Synartro Questions
The Synartro annual revenue was $3 million in 2026.
Antonio Bermejo Gómez is the Chief Development Officer (CDO) of Synartro.
2 people are employed at Synartro.
Synartro is based in Stockholm, Stockholm County.
The NAICS codes for Synartro are [3254, 32, 325, 32541].
The SIC codes for Synartro are [283, 28].
Top Synartro Employees
Related Companies
